Quotes

Back To Menu

Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Large Cap

Invest

18 Apr 2019 | 03:59 PM

1,298.10
-1.90 (-0.15%)

  • Outperforms Index

    10.03%

    Return (1Y)

    Beaten S&P BSE Healthcare by 4.61%

  • More Volatile

    1.74%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.65%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

1,812

1,812.00

1,136

1,135.88

News & Announcements

  • GlaxoSmithKline Pharmaceuticals schedules board meeting

    9 days ago

  • Board of Glaxosmithkline Pharmaceuticals appoints director

    22 days ago

  • Board of Glaxosmithkline Pharmaceuticals accepts resignation of director

    22 days ago

  • Glaxosmithkline Pharmaceuticals standalone net profit rises 25.96% in the December 2018 quarter

    73 days ago

Price vs Volume

Stock Trivia

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 3.89% since past 3 Months

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -10.99% since past 1 Year

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 18.35% since past 1 Year

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...